EMD Serono
PharmaDarmstadt, Germany, Germany · Est. 1846
EMD Serono is a biopharmaceutical company specializing in innovative therapies for oncology, fertility, and neurological disorders.
0
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
0
Indications↗
Distinct diseases across all programs
78
Clinical Trials↗
All sponsored trials (all statuses)
12
Orange Book Patents
Across 3 drugs with upcoming expirations
Activity
Key Events
Details
Company Info
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Therapeutic Focus
OncologyFertilityNeurodegenerative DiseasesImmunology
Regulatory
Regulatory Timeline
19931 event
FDAFeb 26
Leustatin — LEUSTATIN
Application NDA020229 (NDA)
19953 events
FDADec 29
Genotropin — NUTROPIN AQ NUSPIN 10
Application BLA020522 (BLA)
FDAAug 24
Genotropin — GENOTROPIN
Application BLA020280 (BLA)
FDAMay 25
Genotropin — ZOMACTON
Application BLA019774 (BLA)
19962 events
FDAAug 23
Genotropin — SEROSTIM
Application BLA020604 (BLA)
FDAMay 17
Avonex — AVONEX
Application BLA103628 (BLA)
19971 event
FDASep 29
Gonal-f — GONAL-F
Application BLA020378 (BLA)
19981 event
FDANov 5
Glucophage — GLUCOPHAGE
Application NDA020357 (NDA)
20003 events
FDAOct 13
Glucophage — GLUCOPHAGE XR
Application NDA021202 (NDA)
FDAAug 11
Cetrotide — CETROTIDE
Application NDA021197 (NDA)
FDAJun 20
Genotropin — NORDITROPIN
Application BLA021148 (BLA)
20021 event
FDAMar 7
Avonex — REBIF
Application BLA103780 (BLA)
20031 event
FDASep 11
Glucophage — RIOMET
Application NDA021591 (NDA)
20041 event
FDAApr 27
Glucophage — FORTAMET
Application NDA021574 (NDA)
20051 event
FDAJun 3
Glucophage — GLUMETZA
Application NDA021748 (NDA)
20061 event
FDAMay 30
Genotropin — OMNITROPE
Application BLA021426 (BLA)
20171 event
FDAMar 23
Bavencio — BAVENCIO
Application BLA761049 (BLA)
20192 events
FDAAug 29
Glucophage — RIOMET ER
Application NDA212595 (NDA)
FDAMar 29
Leustatin — MAVENCLAD
Application NDA022561 (NDA)
20211 event
FDAFeb 3
Tepmetko — TEPMETKO
Application NDA214096 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)